group-women-sports-teams

News & Media

Take a look inside our world

Press Releases



Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth


Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)


Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel


Teva and Samsung Bioepis Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States


Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference


Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025


Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease


Teva Announces New Patient Access Program with Direct Relief


Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan


Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
View all press releases

Feature stories


Woman using inhaler device for asthma

Medical Device Engineering: the Teva Story

Dr Beatrice Wiafe Addai addressing breast cancer meeting in Ghana

Behind the Numbers: Working to Tackle Breast Cancer in Ghana

Mark DeStefano, Director of Global Technology Innovation for the CPD R&D group at Teva

3 Trends I’m Watching in Drug Delivery Devices

Beryl Ojwang, MD, MBA, MPH, Global Associate Medical Director in Neuroscience, shares how technology helps generate patient insights for Teva scientists.

“AI helps us better understand and support patient needs”

Teva team outdoor

Teva Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index

Teva scientist working on duvakitug in lab

Addressing the unmet needs of Inflammatory Bowel Disease patients

Konstantina Katcheves, SVP Innovative Business Development

3 Trends

3 Trends I’m Watching in Pharma Business Development

Two women standing in a forest

Goodbye? More Like “See You Later!” Teva’s Boomerang Employees

Navdeep Boparai

"I have learned more from ‘successful failures’ than clear-cut wins"

Irit Hovich, Global I&D Lead at Teva

“We All Deserve to Feel Like We Belong”
View all stories

Contacts for Media Inquiries

Kelley Dougherty

North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Fiona Cohen

Europe

fiona.cohen@tevaeu.com

Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll

Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com